Breaking News Headlines Today

News about Novo Nordisk

Stay current with all the latest and breaking news about Novo Nordisk, compare headlines and perspectives between news sources on stories happening today. In total, 251 stories have been published about Novo Nordisk which Ground News has aggregated in the past 3 months.

Covered Most By

foreignpolicyjournal.com

Far Left

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

News about Novo Nordisk

News about Novo Nordisk

Covered Most By

Local News Publishers

Top Novo Nordisk News

Novo CEO Faces Investor Grilling After Outlook Hike

Novo Fails to Shrug Off Investor Concern at Q2 Update

Novo Nordisk partners Amazon on London AI hub

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Novo Nordisk

Novo Nordisk partners Amazon on London AI hub

Novo and Eli Lilly Win in Competition Case

Sweden Lost Its Novo Nordisk in 1999: Now Rumors Are Ripping up the Past

Novo Nordisk: This Is What a Top Manager Says Before the Start of Germany

A Major Anti-Inflammatory Heart Drug Trial Failed, Testing a Leading Theory About Artery Disease

More Brits Than Ever Are Going Under The Knife To Fix Ozempic Face

The Pain Is Not over for Novo Nordisk. First Came the Disappointment, Now the Real Downturn Threatens

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Novo Boss Wants Employees to Run Faster and Work More in the Midst of Crisis: 'Unworthy' and 'a Harsh Signal', Say Unions

Major Bank Lacks Clarity on Strategy From Mike Doustdar

Novo Nordisk partners Amazon on London AI hub

Novo and Eli Lilly Win in Competition Case

Sweden Lost Its Novo Nordisk in 1999: Now Rumors Are Ripping up the Past

Novo Nordisk: This Is What a Top Manager Says Before the Start of Germany

A Major Anti-Inflammatory Heart Drug Trial Failed, Testing a Leading Theory About Artery Disease

More Brits Than Ever Are Going Under The Knife To Fix Ozempic Face

The Pain Is Not over for Novo Nordisk. First Came the Disappointment, Now the Real Downturn Threatens

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Novo Boss Wants Employees to Run Faster and Work More in the Midst of Crisis: 'Unworthy' and 'a Harsh Signal', Say Unions

Major Bank Lacks Clarity on Strategy From Mike Doustdar

News about Novo Nordisk

News about Novo Nordisk

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Novo Nordisk News

Novo CEO Faces Investor Grilling After Outlook Hike

Novo Fails to Shrug Off Investor Concern at Q2 Update

Novo Nordisk partners Amazon on London AI hub

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Novo Nordisk

Novo Nordisk partners Amazon on London AI hub

Novo and Eli Lilly Win in Competition Case

Sweden Lost Its Novo Nordisk in 1999: Now Rumors Are Ripping up the Past

Novo Nordisk: This Is What a Top Manager Says Before the Start of Germany

A Major Anti-Inflammatory Heart Drug Trial Failed, Testing a Leading Theory About Artery Disease

More Brits Than Ever Are Going Under The Knife To Fix Ozempic Face

The Pain Is Not over for Novo Nordisk. First Came the Disappointment, Now the Real Downturn Threatens

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Novo Boss Wants Employees to Run Faster and Work More in the Midst of Crisis: 'Unworthy' and 'a Harsh Signal', Say Unions

Major Bank Lacks Clarity on Strategy From Mike Doustdar

Novo Nordisk partners Amazon on London AI hub

Novo and Eli Lilly Win in Competition Case

Sweden Lost Its Novo Nordisk in 1999: Now Rumors Are Ripping up the Past

Novo Nordisk: This Is What a Top Manager Says Before the Start of Germany

A Major Anti-Inflammatory Heart Drug Trial Failed, Testing a Leading Theory About Artery Disease

More Brits Than Ever Are Going Under The Knife To Fix Ozempic Face

The Pain Is Not over for Novo Nordisk. First Came the Disappointment, Now the Real Downturn Threatens

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Novo Boss Wants Employees to Run Faster and Work More in the Midst of Crisis: 'Unworthy' and 'a Harsh Signal', Say Unions

Major Bank Lacks Clarity on Strategy From Mike Doustdar

Local News Publishers